Cassava Sciences confirms an FDA clinical hold on its simufilam epilepsy trial, delaying plans and requiring more data despite strong cash reserves.
Yardbarker on MSN
Ryan Pepiot Is One Tweak Away From Frontline Starter Status
As the trade market begins to take shape, Ryan Pepiot is a name that may be more prominent in front office discussions than ...
Discover how S-Scores measure investor sentiment via social media analysis, helping with market decisions and stock performance predictions.
Fidelity's target-date strategies produced positive absolute returns during Q3. Click here to explore our disciplined ...
Discover how the employment-to-population ratio reveals labor market health by comparing employed individuals to the working-age population, with fewer fluctuations than unemployment rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results